.Atea Pharmaceuticals' antiviral has failed another COVID-19 test, yet the biotech still stores out ...
.Neurocrine Biosciences' mental illness program pivot has actually failed. The biotech was actually ...
.Sanofi has made an overdue entry to the radioligand event, paying out 100 thousand euros ($ 110 mil...
.After F2G's first effort to get a brand-new class of antifungal to market was wrecked due to the FD...
.Moderna has actually pledged to cut R&D costs through $1.1 billion through 2027. The choice to s...
.Just four months after Sanofi wager $80 thousand in ahead of time cash on Key Rehabs' losmapimod, t...
.Cancer cells company Oncternal Therapeutics is folding all its medical tests and also laying off pe...
.Roche is keeping out hopes that its injectable excessive weight possibility can at some point displ...
.Novo Nordisk has elevated the cover on a period 1 trial of its own dental amylin as well as GLP-1 r...
.Only a couple of short full weeks after gaining an FDA Fast Track tag for its investigational BTK d...